The medical device contract research organization (cro) market size has grown strongly in recent years. It will grow from $10.64 billion in 2025 to $11.39 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing complexity of medical device regulations, growth in medical device innovation pipelines, rising clinical trial costs, limited in-house regulatory expertise, expansion of global clinical studies.
The medical device contract research organization (cro) market size is expected to see strong growth in the next few years. It will grow to $14.75 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for accelerated device approvals, rising adoption of decentralized clinical trials, growing use of real-world evidence, expansion of post-market surveillance requirements, increasing integration of digital health technologies. Major trends in the forecast period include increasing outsourcing of clinical trial management, rising demand for regulatory compliance expertise, growing adoption of data-driven clinical research, expansion of remote and hybrid clinical monitoring models, enhanced focus on risk-based quality management.
The rise in clinical trials is anticipated to boost the growth of the medical device contract research organization (CRO) market. Clinical trials involve research studies with human participants aimed at assessing the safety and efficacy of new medical treatments, interventions, or diagnostic procedures. The growing number of clinical trials is driven by increased demand for innovative medical devices and regulatory requirements for thorough testing. Medical device contract research organizations (CROs) offer specialized expertise and resources to manage, conduct, and oversee these trials, ensuring compliance and efficiency. For example, in August 2024, the National Library of Medicine reported an increase in registered clinical trials from 477,227 in 2023 to 506,371 across 50 states and 221 countries. Additionally, 52,731 medical device studies were registered globally. This surge in clinical trials is expected to propel the medical device CRO market.
Leading companies in the medical device CRO market are focusing on integrating traditional services with advanced technologies and recruitment strategies, such as hybrid and virtual trial models, to improve trial efficiency, speed up participant enrollment, and streamline regulatory compliance. Virtual and hybrid site capabilities are designed to meet diverse study requirements and participant needs, particularly in response to the growing demand for decentralized trials. For instance, in June 2024, Lindus Health, a UK-based clinical trials company, introduced All-in-One Medical Device CRO, a comprehensive solution tailored for medical device trials. This offering combines traditional CRO services with advanced features such as Citrus eClinical technology. It integrates all essential trial tools into a single platform, including clinical trial management systems (CTMS), electronic data capture (EDC), and eConsent. The platform enhances recruitment with access to over 30 million electronic health records (EHRs) and strategic digital marketing, ensuring efficient and timely enrollment. Lindus Health also provides robust site services, managing trials across single-site, multi-site, and virtual/hybrid models through strong relationships with principal investigators and research staff.
In October 2023, Avania, a US-based clinical research organization that specializes in medical technology development, acquired HULL ASSOCIATES LLC and Ironstone Product Development (IPD) for an undisclosed amount. This acquisition is intended to enhance Avania's global capabilities in regulatory affairs, clinical trial management, and product development services. HULL ASSOCIATES LLC is a US-based consultancy that specializes in regulatory strategies, while Ironstone Product Development (IPD) is a Canada-based company focused on medical device development and commercialization strategies.
Major companies operating in the medical device contract research organization (cro) market are Thermo Fisher Scientific Inc., IQVIA Inc., Laboratory Corporation of America Holdings, ICON plc, Eurofins Scientific SE, WuXi AppTec, Syneos Health, Charles River Laboratories, PAREXEL International, Medpace Holdings Inc., Hangzhou Tigermed Consulting Co. Ltd., Caidya, QPS Holdings LLC, Avania B.V., Veristat, Cromsource S.R.L., Osmunda Medical Technology Service Group, MedTrials Inc., Boston Biomedical Associates, Hangzhou CIRS Technology Group Co. Ltd., Clinlogix, Shanghai Haofeng Medical Technology Co. Ltd., Promedica International, Medidee Services.
Asia-Pacific was the largest region in the medical device contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract research organization (cro) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device contract research organization (cro) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the medical device CRO market by increasing costs of imported laboratory equipment, clinical trial supplies, diagnostic tools, and data management infrastructure. CRO operations supporting multinational trials in North America and Europe are most affected due to cross-border sourcing dependencies, while Asia-Pacific faces cost pressures on trial execution services. These tariffs are increasing overall study budgets and operational expenses. At the same time, they are encouraging regional trial localization, local vendor partnerships, and investment in domestic clinical research capabilities.
The medical device contract research organization (cro) market research report is one of a series of new reports that provides medical device contract research organization (cro) market statistics, including medical device contract research organization (cro) industry global market size, regional shares, competitors with a medical device contract research organization (cro) market share, detailed medical device contract research organization (cro) market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract research organization (cro) industry. This medical device contract research organization (cro) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical device contract research organization (CRO) is a specialized service provider that offers outsourced research and development support to medical device manufacturers. These organizations assist companies in navigating the complex process of developing a medical device from concept to market, ensuring regulatory compliance, and achieving successful clinical outcomes. CROs play a critical role in reducing the time, cost, and risks associated with medical device development.
Key services provided by medical device CROs include project management or clinical supply management, regulatory or medical affairs, medical writing, clinical monitoring, quality management or assurance, biostatistics, investigator payments, laboratory services, patient and site recruitment, and more. Project management or clinical supply management focuses on overseeing the planning, execution, and coordination of clinical trials, ensuring that necessary supplies, including medical devices and drugs, are available at trial sites. The types of devices covered include medtech devices, diagnostic devices, handheld devices, and others. The phases include preclinical and clinical, with applications spanning cardiology, diagnostic imaging, orthopedics, in vitro diagnostics (IVD), ophthalmology, general and plastic surgery, and drug delivery.
The medical device contract research organization (CRO) market includes revenues earned by companies providing outsourced research and development services, such as clinical trials, regulatory affairs, and product development support, to medical device manufacturers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical device contract research organization (cro) market size is expected to see strong growth in the next few years. It will grow to $14.75 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for accelerated device approvals, rising adoption of decentralized clinical trials, growing use of real-world evidence, expansion of post-market surveillance requirements, increasing integration of digital health technologies. Major trends in the forecast period include increasing outsourcing of clinical trial management, rising demand for regulatory compliance expertise, growing adoption of data-driven clinical research, expansion of remote and hybrid clinical monitoring models, enhanced focus on risk-based quality management.
The rise in clinical trials is anticipated to boost the growth of the medical device contract research organization (CRO) market. Clinical trials involve research studies with human participants aimed at assessing the safety and efficacy of new medical treatments, interventions, or diagnostic procedures. The growing number of clinical trials is driven by increased demand for innovative medical devices and regulatory requirements for thorough testing. Medical device contract research organizations (CROs) offer specialized expertise and resources to manage, conduct, and oversee these trials, ensuring compliance and efficiency. For example, in August 2024, the National Library of Medicine reported an increase in registered clinical trials from 477,227 in 2023 to 506,371 across 50 states and 221 countries. Additionally, 52,731 medical device studies were registered globally. This surge in clinical trials is expected to propel the medical device CRO market.
Leading companies in the medical device CRO market are focusing on integrating traditional services with advanced technologies and recruitment strategies, such as hybrid and virtual trial models, to improve trial efficiency, speed up participant enrollment, and streamline regulatory compliance. Virtual and hybrid site capabilities are designed to meet diverse study requirements and participant needs, particularly in response to the growing demand for decentralized trials. For instance, in June 2024, Lindus Health, a UK-based clinical trials company, introduced All-in-One Medical Device CRO, a comprehensive solution tailored for medical device trials. This offering combines traditional CRO services with advanced features such as Citrus eClinical technology. It integrates all essential trial tools into a single platform, including clinical trial management systems (CTMS), electronic data capture (EDC), and eConsent. The platform enhances recruitment with access to over 30 million electronic health records (EHRs) and strategic digital marketing, ensuring efficient and timely enrollment. Lindus Health also provides robust site services, managing trials across single-site, multi-site, and virtual/hybrid models through strong relationships with principal investigators and research staff.
In October 2023, Avania, a US-based clinical research organization that specializes in medical technology development, acquired HULL ASSOCIATES LLC and Ironstone Product Development (IPD) for an undisclosed amount. This acquisition is intended to enhance Avania's global capabilities in regulatory affairs, clinical trial management, and product development services. HULL ASSOCIATES LLC is a US-based consultancy that specializes in regulatory strategies, while Ironstone Product Development (IPD) is a Canada-based company focused on medical device development and commercialization strategies.
Major companies operating in the medical device contract research organization (cro) market are Thermo Fisher Scientific Inc., IQVIA Inc., Laboratory Corporation of America Holdings, ICON plc, Eurofins Scientific SE, WuXi AppTec, Syneos Health, Charles River Laboratories, PAREXEL International, Medpace Holdings Inc., Hangzhou Tigermed Consulting Co. Ltd., Caidya, QPS Holdings LLC, Avania B.V., Veristat, Cromsource S.R.L., Osmunda Medical Technology Service Group, MedTrials Inc., Boston Biomedical Associates, Hangzhou CIRS Technology Group Co. Ltd., Clinlogix, Shanghai Haofeng Medical Technology Co. Ltd., Promedica International, Medidee Services.
Asia-Pacific was the largest region in the medical device contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract research organization (cro) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device contract research organization (cro) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the medical device CRO market by increasing costs of imported laboratory equipment, clinical trial supplies, diagnostic tools, and data management infrastructure. CRO operations supporting multinational trials in North America and Europe are most affected due to cross-border sourcing dependencies, while Asia-Pacific faces cost pressures on trial execution services. These tariffs are increasing overall study budgets and operational expenses. At the same time, they are encouraging regional trial localization, local vendor partnerships, and investment in domestic clinical research capabilities.
The medical device contract research organization (cro) market research report is one of a series of new reports that provides medical device contract research organization (cro) market statistics, including medical device contract research organization (cro) industry global market size, regional shares, competitors with a medical device contract research organization (cro) market share, detailed medical device contract research organization (cro) market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract research organization (cro) industry. This medical device contract research organization (cro) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical device contract research organization (CRO) is a specialized service provider that offers outsourced research and development support to medical device manufacturers. These organizations assist companies in navigating the complex process of developing a medical device from concept to market, ensuring regulatory compliance, and achieving successful clinical outcomes. CROs play a critical role in reducing the time, cost, and risks associated with medical device development.
Key services provided by medical device CROs include project management or clinical supply management, regulatory or medical affairs, medical writing, clinical monitoring, quality management or assurance, biostatistics, investigator payments, laboratory services, patient and site recruitment, and more. Project management or clinical supply management focuses on overseeing the planning, execution, and coordination of clinical trials, ensuring that necessary supplies, including medical devices and drugs, are available at trial sites. The types of devices covered include medtech devices, diagnostic devices, handheld devices, and others. The phases include preclinical and clinical, with applications spanning cardiology, diagnostic imaging, orthopedics, in vitro diagnostics (IVD), ophthalmology, general and plastic surgery, and drug delivery.
The medical device contract research organization (CRO) market includes revenues earned by companies providing outsourced research and development services, such as clinical trials, regulatory affairs, and product development support, to medical device manufacturers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Device Contract Research Organization (CRO) Market Characteristics
3. Medical Device Contract Research Organization (CRO) Market Supply Chain Analysis
4. Global Medical Device Contract Research Organization (CRO) Market Trends and Strategies
5. Medical Device Contract Research Organization (CRO) Market Analysis of End Use Industries
7. Global Medical Device Contract Research Organization (CRO) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Device Contract Research Organization (CRO) Total Addressable Market (TAM) Analysis for the Market
9. Medical Device Contract Research Organization (CRO) Market Segmentation
10. Medical Device Contract Research Organization (CRO) Market Regional and Country Analysis
11. Asia-Pacific Medical Device Contract Research Organization (CRO) Market
12. China Medical Device Contract Research Organization (CRO) Market
13. India Medical Device Contract Research Organization (CRO) Market
14. Japan Medical Device Contract Research Organization (CRO) Market
15. Australia Medical Device Contract Research Organization (CRO) Market
16. Indonesia Medical Device Contract Research Organization (CRO) Market
17. South Korea Medical Device Contract Research Organization (CRO) Market
18. Taiwan Medical Device Contract Research Organization (CRO) Market
19. South East Asia Medical Device Contract Research Organization (CRO) Market
20. Western Europe Medical Device Contract Research Organization (CRO) Market
21. UK Medical Device Contract Research Organization (CRO) Market
22. Germany Medical Device Contract Research Organization (CRO) Market
23. France Medical Device Contract Research Organization (CRO) Market
24. Italy Medical Device Contract Research Organization (CRO) Market
25. Spain Medical Device Contract Research Organization (CRO) Market
26. Eastern Europe Medical Device Contract Research Organization (CRO) Market
27. Russia Medical Device Contract Research Organization (CRO) Market
28. North America Medical Device Contract Research Organization (CRO) Market
29. USA Medical Device Contract Research Organization (CRO) Market
30. Canada Medical Device Contract Research Organization (CRO) Market
31. South America Medical Device Contract Research Organization (CRO) Market
32. Brazil Medical Device Contract Research Organization (CRO) Market
33. Middle East Medical Device Contract Research Organization (CRO) Market
34. Africa Medical Device Contract Research Organization (CRO) Market
36. Medical Device Contract Research Organization (CRO) Market Competitive Landscape and Company Profiles
37. Medical Device Contract Research Organization (CRO) Market Other Major and Innovative Companies
40. Medical Device Contract Research Organization (CRO) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Device Contract Research Organization (CRO) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical device contract research organization (cro) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical device contract research organization (cro)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device contract research organization (cro) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Service: Project Management Or Clinical Supply Management; Regulatory Or Medical Affairs; Medical Writing; Clinical Monitoring; Quality Management Or Assurance; Bio Statistics; Investigator Payments; Laboratory; Patient And Site Recruitment; Other Services2) By Device Type: MedTech Devices; Diagnostic Devices; Handheld Devices; Other Device Types
3) By Phase: Preclinical; Clinical
4) By Application: Cardiology; Diagnostic Imaging; Orthopedic; In Vitro Diagnostics (IVD); Ophthalmic; General And Plastic Surgery; Cardiovascular And Implantable Devices
Subsegments:
1) By Project Management Or Clinical Supply Management: Study Planning and Coordination; Clinical Supply Chain Management; Vendor Management2) By Regulatory or Medical Affairs: Regulatory Strategy Development; Medical Affairs Support; Regulatory Submission Preparation
3) By Medical Writing: Clinical Study Protocols; Clinical Study Reports (CSRs); Regulatory Submission Documents; Patient Information Leaflets
4) By Clinical Monitoring: Site Selection and Initiation; On-site Monitoring Visits; Remote Monitoring; Data Verification
5) By Quality Management or Assurance: Quality Assurance Audits; Standard Operating Procedure (SOP) Development; Compliance Management
6) By Biostatistics: Statistical Analysis Plan Development; Data Management And Analysis; Clinical Trial Design
7) By Investigator Payments: Payment Processing Services; Financial Disclosure Management
8) By Laboratory Services: Clinical Laboratory Testing; Bioanalytical Testing; Pathology Services
9) By Patient And Site Recruitment: Site Feasibility Assessment; Patient Recruitment Strategies; Retention And Engagement Strategies
10) By Other Services: Training And Education; Risk Management; Post-Market Surveillance; Data Management Services.
Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA Inc.; Laboratory Corporation of America Holdings; ICON plc; Eurofins Scientific SE; WuXi AppTec; Syneos Health; Charles River Laboratories; PAREXEL International; Medpace Holdings Inc.; Hangzhou Tigermed Consulting Co. Ltd.; Caidya; QPS Holdings LLC; Avania B.V.; Veristat; Cromsource S.R.L.; Osmunda Medical Technology Service Group; MedTrials Inc.; Boston Biomedical Associates; Hangzhou CIRS Technology Group Co. Ltd.; Clinlogix; Shanghai Haofeng Medical Technology Co. Ltd.; Promedica International; Medidee Services
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Device Contract Research Organization (CRO) market report include:- Thermo Fisher Scientific Inc.
- IQVIA Inc.
- Laboratory Corporation of America Holdings
- ICON plc
- Eurofins Scientific SE
- WuXi AppTec
- Syneos Health
- Charles River Laboratories
- PAREXEL International
- Medpace Holdings Inc.
- Hangzhou Tigermed Consulting Co. Ltd.
- Caidya
- QPS Holdings LLC
- Avania B.V.
- Veristat
- Cromsource S.R.L.
- Osmunda Medical Technology Service Group
- MedTrials Inc.
- Boston Biomedical Associates
- Hangzhou CIRS Technology Group Co. Ltd.
- Clinlogix
- Shanghai Haofeng Medical Technology Co. Ltd.
- Promedica International
- Medidee Services
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.39 Billion |
| Forecasted Market Value ( USD | $ 14.75 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
